• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Accolade Inc (NQ: ACCD )

    3.200 +0.030 (+0.95%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,326,305
    Open 3.170
    Bid (Size) 3.160 (2)
    Ask (Size) 3.260 (10)
    Prev. Close 3.170
    Today's Range 3.140 - 3.275
    52wk Range 3.130 - 15.36
    Shares Outstanding 76,232,192
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Forecasting The Future: 6 Analyst Projections For Accolade
    Via Benzinga
    Accolade's Q2 Boost: Revenue Rises, Losses Shrink, And Profitability Looms
    Accolade stock up after beating Q2 2025 revenue and EPS estimates, expecting full year Adjusted EBITDA profitability and positive cash flow. 
    Via Benzinga

    Performance

    YTD
    -73.58%
    -73.58%
    1 Month
    -13.04%
    -13.04%
    3 Month
    -12.09%
    -12.09%
    6 Month
    -58.06%
    -58.06%
    1 Year
    -55.92%
    -55.92%

    More News

    Read More
    Accolade Announces Results for Fiscal Second Quarter 2025
    From Accolade, Inc.
    Via GlobeNewswire
    Dow Dips Around 400 Points As Treasury Yields Top 4%: Investor Optimism Declines, But Fear Index Remains In 'Greed' Zone
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    PepsiCo, MEDIROM Healthcare Technologies And 3 Stocks To Watch Heading Into Tuesday
    Via Benzinga
    Uncovering Potential: Accolade's Earnings Preview
    Via Benzinga
    Top Wall Street Forecasters Revamp Accolade Price Expectations Ahead Of Q2 Earnings
    Via Benzinga
    Accolade Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Accolade, Inc. (ACCD) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    Accolade, Inc. (ACCD) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    Apple To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday
    Via Benzinga
    Nike, Accolade And Other Big Stocks Moving Lower In Friday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    Via InvestorPlace
    ACCD Investors Have the Opportunity to Join Accolade, Inc. Securities Fraud Investigation with The Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    ACCD Stock Earnings: Accolade Beats EPS, Beats Revenue for Q1 2025
    Via InvestorPlace
    Accolade Stock Tumbles On Q1 Earnings, Weak Guidance: What You Need To Know
    Via Benzinga
    Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
    Via The Motley Fool
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    ACCD Stock Earnings: Accolade Misses EPS, Beats Revenue for Q4 2024
    Via InvestorPlace
    Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2024
    From Accolade, Inc.
    Via GlobeNewswire
    Alphabet To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Monday
    Via Benzinga
    Alabama’s Fertility Ruling Raises Challenges for Stocks of Fertility Benefits Providers
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.